140 related articles for article (PubMed ID: 36357161)
21. The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
Christensen IE; Jyssum I; Tveter AT; Sexton J; Tran TT; Mjaaland S; Kro GB; Kvien TK; Warren DJ; Jahnsen J; Munthe LA; Haavardsholm EA; Vaage JT; Grødeland G; Lund-Johansen F; Jørgensen KK; Syversen SW; Goll GL; Provan SA
BMC Med; 2022 Oct; 20(1):378. PubMed ID: 36199139
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants.
DeSantis SM; Yaseen A; Hao T; León-Novelo L; Talebi Y; Valerio-Shewmaker MA; Pinzon Gomez CL; Messiah SE; Kohl HW; Kelder SH; Ross JA; Padilla LN; Silberman M; Tuzo S; Lakey D; Shuford JA; Pont SJ; Boerwinkle E; Swartz MD
J Infect Dis; 2023 May; 227(10):1164-1172. PubMed ID: 36729177
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
Torres I; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Burgos JS; Peiró S; Limón R; Vanaclocha H; Rodado C; Botija P; Sifre A; Tur B; Lozano RA; Orosa I; Vicente-Ruiz M; Carrión RJ; Clari MÁ; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Geller R; Navarro D;
J Med Virol; 2022 Sep; 94(9):4216-4223. PubMed ID: 35585782
[TBL] [Abstract][Full Text] [Related]
24. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults.
Nishimi K; Neylan TC; Bertenthal D; Seal KH; O'Donovan A
JAMA Netw Open; 2022 Apr; 5(4):e227287. PubMed ID: 35420660
[TBL] [Abstract][Full Text] [Related]
25. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
26. Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases.
Dayam RM; Law JC; Goetgebuer RL; Chao GY; Abe KT; Sutton M; Finkelstein N; Stempak JM; Pereira D; Croitoru D; Acheampong L; Rizwan S; Rymaszewski K; Milgrom R; Ganatra D; Batista NV; Girard M; Lau I; Law R; Cheung MW; Rathod B; Kitaygorodsky J; Samson R; Hu Q; Hardy WR; Haroon N; Inman RD; Piguet V; Chandran V; Silverberg MS; Gingras AC; Watts TH
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35471956
[TBL] [Abstract][Full Text] [Related]
27. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort.
Zhu XY; Lu YF; Xue F; Luo Y; Feng MX; Qiu BJ; Zhou T; Zhu JJ; Zhang JJ; Wan P; Xia Q
Virol J; 2023 Feb; 20(1):28. PubMed ID: 36774503
[TBL] [Abstract][Full Text] [Related]
29. Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection.
Jeong HW; Kim SM; Jung MK; Noh JY; Yoo JS; Kim EH; Kim YI; Yu K; Jang SG; Gil J; Casel MA; Rare R; Choi JH; Kim HS; Kim JH; Um J; Kim C; Kim Y; Chin BS; Jung S; Choi JY; Song KH; Kim YD; Park JS; Song JY; Shin EC; Choi YK
Cell Rep Med; 2022 Oct; 3(10):100764. PubMed ID: 36182684
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort study.
Kim WJ; Choi SH; Park JY; Song JS; Chung JW; Choi ST
Ann Rheum Dis; 2022 Nov; 81(11):1585-1593. PubMed ID: 35878999
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
Piñana JL; López-Corral L; Martino R; Vazquez L; Pérez A; Martin-Martin G; Gago B; Sanz-Linares G; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; Corona M; Marcos-Corrales S; Tormo M; Hernández-Rivas JÁ; Montoro J; Rodriguez-Fernandez A; Risco-Gálvez I; Rodríguez-Belenguer P; Hernandez-Boluda JC; García-Cadenas I; Ruiz-García M; Muñoz-Bellido JL; Solano C; Cedillo Á; Sureda A; Navarro D;
J Hematol Oncol; 2022 May; 15(1):54. PubMed ID: 35526045
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
Simon D; Tascilar K; Fagni F; Krönke G; Kleyer A; Meder C; Atreya R; Leppkes M; Kremer AE; Ramming A; Pachowsky ML; Schuch F; Ronneberger M; Kleinert S; Hueber AJ; Manger K; Manger B; Berking C; Sticherling M; Neurath MF; Schett G
Ann Rheum Dis; 2021 Oct; 80(10):1312-1316. PubMed ID: 33958324
[TBL] [Abstract][Full Text] [Related]
33. Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections.
Huapaya JA; Higgins J; Kanth S; Demirkale CY; Gairhe S; Aboye EA; Regenold D; Sahagun SJ; Pastor G; Swaim D; Dewar R; Rehman T; Highbarger HC; Lallemand P; Laverdure S; Adelsberger J; Rupert A; Li W; Krack J; Teferi G; Kuruppu J; Strich JR; Davey R; Childs R; Chertow D; Kovacs JA; Barnett C; Torabi-Parizi P; Suffredini AF;
J Infect Dis; 2023 Jun; 228(1):46-58. PubMed ID: 36801946
[TBL] [Abstract][Full Text] [Related]
34. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
Wang W; Kaelber DC; Xu R; Berger NA
JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Analysis of SARS-CoV-2 Serological Responses Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections.
Macrae K; Gong CY; Sheth P; Martinez-Cajas J; Gong Y
Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298455
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of COVID-19 vaccines in patients taking immunosuppressants.
Shen C; Risk M; Schiopu E; Hayek SS; Xie T; Holevinski L; Akin C; Freed G; Zhao L
Ann Rheum Dis; 2022 Jun; 81(6):875-880. PubMed ID: 35197265
[TBL] [Abstract][Full Text] [Related]
37. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
38. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.
Andeweg SP; de Gier B; Eggink D; van den Ende C; van Maarseveen N; Ali L; Vlaemynck B; Schepers R; Hahné SJM; Reusken CBEM; de Melker HE; van den Hof S; Knol MJ
Nat Commun; 2022 Aug; 13(1):4738. PubMed ID: 35961956
[TBL] [Abstract][Full Text] [Related]
39. Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel.
Cohen MJ; Oster Y; Moses AE; Spitzer A; Benenson S;
JAMA Netw Open; 2022 Aug; 5(8):e2224657. PubMed ID: 35917125
[TBL] [Abstract][Full Text] [Related]
40. Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases.
Li H; Wang Y; Ao L; Ke M; Chen Z; Chen M; Peng M; Ling N; Hu P; Cai D; Zhang D; Ren H
Front Immunol; 2022; 13():988004. PubMed ID: 36275639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
